Trials / Completed
CompletedNCT01221584
Centralized Pan-Russian Survey on the Undertreatment of Hypercholesterolemia
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to establish the proportion of patients on lipid-lowering pharmacological treatment reaching the LDL-C goals according to the All-Russian Scientific Cardiology Society guidelines/ the 4th Joint European Task Force guidelines.
Conditions
Timeline
- Start date
- 2010-10-01
- Primary completion
- 2011-03-01
- Completion
- 2011-03-01
- First posted
- 2010-10-15
- Last updated
- 2012-03-01
Locations
8 sites across 1 country: Russia
Source: ClinicalTrials.gov record NCT01221584. Inclusion in this directory is not an endorsement.